Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy

References

• Iba T, et al. The unique characteristics of COVID-19 coagulopathy. Crit Care. 2020;24(1):1–8.https://doi.org/10.1186/s13054-020-03077-0.
   PubMed Web of Science ®Google Scholar
• COVID-19 and its implications for thrombosis and anticoagulation. Hospital Medicine Virtual Journal Club. 2020. https://journalclub.wustl.edu/2020/04/28/covid-19-and-its-implications-for-thrombosis-and-anticoagulation/. Accessed 9 May 2020.
   Google Scholar
• JH C. Thromboinflammation and the hypercoagulability of COVID-19. 2020. https://www.ncbi.nlm.nih.gov/pubmed/32302453. Accessed 9 May 2020.
   Google Scholar
• Han H, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58(7):1116–1120. https://doi.org/10.1515/cclm-2020-0188.
   PubMed Web of Science ®Google Scholar
• Tandfonline.com. 2020. https://doi.org/10.1080/22221751.2020.1741327. Accessed 9 May 2020.
   Google Scholar
• Magro C, Mulvey J, Berlin D, Nuovo G, Salvatore S, Harp J, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. 2020.
   Google Scholar
• Anticoagulation Guidance Emerging for Severe COVID-19—pragmatic choices dominate as guidelines are shaping up: China_Flu. Reddit.com. 2020. https://www.reddit.com/r/China_Flu/comments/gbrq3h/anticoagulation_guidance_emerging_for_severe/. Accessed 9 May 2020.
   Google Scholar
• Klok F, Kruip M, van der Meer N, Arbous M, Gommers D, Kant K, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–147.
   PubMed Web of Science ®Google Scholar
• Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18:1421–1424.
   PubMed Web of Science ®Google Scholar
• Beun R, Kusadasi N, Sikma M, Westerink J, Huisman A. Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2. Int J Lab Hematol. 2020;42:19–20.
   PubMed Web of Science ®Google Scholar
• Al-Ani F, et al. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res. 2020;192:152–160.https://doi.org/10.1016/j.thromres.2020.05.039.
   PubMed Web of Science ®Google Scholar
• Liu PP, et al. The science underlying COVID-19. Circulation. 2020;142(1):68–78.https://doi.org/10.1161/circulationaha.120.047549.
   PubMed Web of Science ®Google Scholar
• Feature | Thrombosis and COVID-19: FAQs for current practice—American College of Cardiology. American College of Cardiology. 2020. https://www.acc.org/latest-in-cardiology/articles/2020/04/17/14/42/thrombosis-and-coronavirus-disease-2019-covid-19-faqs-for-current-practice. Accessed 9 May 2020.
   Google Scholar
• Al-Samkari H, et al. COVID and coagulation: bleeding and thrombotic manifestations of SARS-CoV2 infection. Blood. 2020. https://doi.org/10.1182/blood.2020006520.
   PubMed Web of Science ®Google Scholar
• Panigada ME. Hypercoagulability of COVID-19 patients in Intensive Care Unit. A report of thromboelastography findings and other parameters of hemostasis. 2020. https://www.ncbi.nlm.nih.gov/pubmed/32302438. Accessed 9 May 2020.
   Google Scholar
• Consult QD. Consult QD. 2020. https://consultqd.clevelandclinic.org/tag/venous-thromboembolism-vte/. Accessed 9 May 2020.
   Google Scholar
• Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, Chen H, Ding X, Zhao H, Zhang H, Wang C. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020. https://doi.org/10.1056/NEJMc2007575.
   Web of Science ®Google Scholar
• Coronavirus (COVID-19) clinical guidance repository. AAMC. 2020. https://www.aamc.org/coronavirus-covid-19-clinical-guidance-repository. Accessed 9 May 2020
   Google Scholar
• Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934–943.
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069.
   PubMed Web of Science ®Google Scholar
• Marietta ME. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). 2020. https://www.ncbi.nlm.nih.gov/pubmed/32281926. Accessed 9 May 2020.
   Google Scholar
• Bowles L, Platton S, Yartey N, Dave M, Lee K, Hart DP, MacDonald V, Green L, Sivapalaratnam S, Pasi KJ, MacCallum P. Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19. N Engl J Med. 2020. https://doi.org/10.1056/NEJMc2013656.
   Web of Science ®Google Scholar
• Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E, et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost. 2020. https://doi.org/10.1055/s-0040-1710018.
   PubMed Web of Science ®Google Scholar
• Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18:1023–1026.
   PubMed Web of Science ®Google Scholar
• Llitjos JF, Leclerc M, Chochois C, Monsallier JM, Ramakers M, Auvray M, Merouani K. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020. https://doi.org/10.1111/jth.14869.
   PubMed Web of Science ®Google Scholar
• (COVID-19) C, Health E, Disease H, Disease L, Management P, Conditions S et al. Blood clots are another dangerous COVID-19 Mystery. WebMD. 2020. https://www.webmd.com/lung/news/20200424/blood-clots-are-another-dangerous-covid-19-mystery. Accessed 9 May 2020.
   Google Scholar
• Ranucci M, Ballotta A, Di Dedda U, Bayshnikova E, Dei Poli M, Resta M, et al. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. 2020;18:1747–1751.
   PubMed Web of Science ®Google Scholar
• Preventing COVID-19 complications with low- and high-dose anticoagulation—Full Text View—ClinicalTrials.gov. Clinicaltrials.gov. 2020. https://clinicaltrials.gov/ct2/show/NCT04345848. Accessed 9 May 2020.
   Google Scholar
• The versatile heparin in COVID‐19. Onlinelibrary.wiley.com. 2020. https://doi.org/10.1111/jth.14821. Accessed 9 May 2020.
   Google Scholar
• Mucha SR, et al. Coagulopathy in COVID-19. Cleveland Clin J Med. 2020. https://doi.org/10.3949/ccjm.87a.ccc024.
   Web of Science ®Google Scholar
• Li X, Ma X. The role of heparin in sepsis: much more than just an anticoagulant. 2020.
   Google Scholar
• Mousavi S, Moradi M, Khorshidahmad T, Motamedi M. Anti-inflammatory effects of heparin and its derivatives: a systematic review. 2020.
   Google Scholar
• E Y. The anti-inflammatory effects of heparin and related compounds. 2020. https://www.ncbi.nlm.nih.gov/pubmed/17727922. Accessed 9 May 2020.
   Google Scholar
• MacLaren R, Stringer K. Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndrome. 2020.
   Google Scholar
• Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, Yaffe MB. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series. J Thromb Haemost. 2020. https://doi.org/10.1111/jth.14828. (Epub ahead of print).
   Web of Science ®Google Scholar
• Intensive Care Medicine, Volume 0, Issue 0. Springer. Link.springer.com. 2020. https://link.springer.com/journal/134/onlineFirst. Accessed 9 May 2020.
   Google Scholar
• Levi M, et al. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438.https://doi.org/10.1016/s2352-3026(20)30145-9.
   PubMed Web of Science ®Google Scholar